Seoul White Korea Presentation

SEOUL WHITE
KOREA
MADE IN KOREA
PRESENTATION 1
COVER TITLE
LOREM IPSUM DOLOR SIT AMET,
CONSECTETUR ADIPISCING ELIT.
About Us
Seoul White Korea, a new brand
that promises more even skin for
Filipinos.
3
The Problem
Declining Market Financial Trust Cost Margins
Lorem ipsum dolor sit Lorem ipsum dolor sit Lorem ipsum dolor sit Lorem ipsum dolor sit Lorem ipsum dolor sit
amet, consectetur amet, consectetur amet, consectetur amet, consectetur amet, consectetur
adipiscing elit. adipiscing elit. adipiscing elit. adipiscing elit. adipiscing elit.
4
Solution
Lorem ipsum dolor sit amet,
consectetur adipiscing elit.
Prioritize Authorize Monetize
Etiam aliquet eu mi quis.
Lorem ipsum dolor sit Lorem ipsum dolor sit Lorem ipsum dolor sit
amet, consectetur amet, consectetur amet, consectetur
adipiscing elit. adipiscing elit. adipiscing elit.
5
Unique First to Market
Lorem ipsum dolor sit Lorem ipsum dolor sit
amet, consectetur amet, consectetur
adipiscing elit. adipiscing elit.
Product
Etiam aliquet eu mi quis.
Tested Authentic
amet, consectetur amet, consectetur
6
Emphasize your
main benefit
Other benefits include
Nunc tempus, risus sodales
sodales hendrerit, arcu dolor.
7
SECTION DIVIDER
CONSECTETUR ADIPISCING ELIT
8
SECTION DIVIDER 1
CONSECTETUR ADIPISCING ELIT
9
Business Model
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Research Invest
Finance
amet, consectetur Lorem ipsum dolor sit amet, consectetur
adipiscing elit. amet, consectetur adipiscing elit.
adipiscing elit.
10
Market Opportunity Option 1
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
$1B $2B
• Lorem ipsum dolor sit amet, • Lorem ipsum ut congue quis
consectetur adipiscing elit. tortor eget sodales. Nulla a
• Etiam aliquet eu mi quis erat eget nunc hendrerit
lacinia. Ut fermentum a ultrices eu nec nulla.
magna ut eleifend. Integer • Donec viverra leo aliquet,
convallis suscipit ante eu auctor quam id, convallis orci.
varius.
• Morbi a purus dolor.
Suspendisse sit amet ipsum
finibus justo viverra blandit.
11
Market Opportunity Option 2
Integer convallis suscipit ante eu varius. Morbi a purus dolor.
$3B
Opportunity to Build
$2B
Freedom to Invent
$1B
Few Competitors
Lorem ipsum dolor sit Lorem ipsum dolor sit Lorem ipsum dolor sit
amet, consectetur amet, consectetur amet, consectetur
adipiscing elit. adipiscing elit. adipiscing elit.
12
Competition Option 1
Contoso Pharmaceuticals Competitor

• Lorem ipsum dolor sit amet, consectetur • Lorem ipsum dolor sit amet, consectetur
• Nulla a erat eget nunc hendrerit ultrices eu nec • Nulla a erat eget nunc hendrerit ultrices eu nec
nulla. Donec viverra leo aliquet, auctor quam id, nulla. Donec viverra leo aliquet, auctor quam id,
convallis orci. convallis orci.
• Sed in molestie est. Cras ornare turpis at ligula • Sed in molestie est. Cras ornare turpis at ligula
posuere, sit amet accumsan neque lobortis. posuere, sit amet accumsan neque lobortis.
• Maecenas mattis risus ligula, sed ullamcorper nunc • Maecenas mattis risus ligula, sed ullamcorper nunc
efficitur sed. efficitur sed.
13
Competition Option 2
Convenience
Contoso
Pharmaceuticals
Expensive Affordable
Inconvenient
14
Growth Strategy
How will we scale in the future
Phase 1 Phase 2 Phase 3

Month, Year Month, Year Month, Year
• Lorem ipsum dolor sit amet, • Lorem ipsum dolor sit amet, • Lorem ipsum dolor sit amet,
consectetur adipiscing elit. consectetur adipiscing elit. consectetur adipiscing elit.
• Etiam aliquet eu mi quis • Etiam aliquet eu mi quis • Etiam aliquet eu mi quis
lacinia. Ut fermentum a lacinia. Ut fermentum a lacinia. Ut fermentum a
magna ut eleifend. Integer magna ut eleifend. Integer magna ut eleifend. Integer
convallis suscipit ante eu convallis suscipit ante eu convallis suscipit ante eu
varius. varius. varius.
15
Traction
Forecasting for success
Vendors Users Gross Company Gross Revenue

Revenue Revenue $300,000
20YY 0 0 $0 $0 $250,000
$200,000
20YY 10 100 $6,750 $1,013
$150,000
20YY 50 500 $33,750 $5,063
$100,000
20YY 200 2000 $135,000 $20,250

$50,000
20YY 400 4000 $270,000 $40,500 $0

1 2 3 4 5
16
Timeline
Our two-year action plan
Trials Marketing Launch

Month, 20YY Month, 20YY Month, 20YY
AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY
20YY 20YY
Legislation Investment Procurement

Month, 20YY Month, 20YY Month, 20YY
17
Financials
Year 1 Year 2 Year 3
Detailers 5,000 40,000 160,000
Users 50,000 400,000 1 600,000
Sales 500,000 4 000,000 16 000,000
Average Price per Sale 75 80 90
Revenue @ 15% 5 625,000 48 000,000 216 000,000
• Cost of Revenue 0 0 0
Gross Profit 5 625,000 48 000,000 216 000,000
Expenses
• Sales & Marketing 5 062,500 38 400,000 151 200,000 70%
• Customer Service 1 687,500 9 600,000 21 600,000 10%
• Product Development 562,500 2 400,000 10 800,000 5%

• Research 281,250 2 400,000 4 320,000 2%
Total Expenses 7 593,750 52 800,000 187 920,000
EBIT -1 968,750 -4 800,000 28 080,000 13%
18
Team
Mirjam Nils Victoria Lindqvist Angelica Astrom

COO COB CFO
Lorem ipsum dolor sit amet, Lorem ipsum dolor sit amet, Lorem ipsum dolor sit amet,
consectetur adipiscing elit. Etiam consectetur adipiscing elit. Etiam consectetur adipiscing elit. Etiam
aliquet eu mi quis lacinia. Ut aliquet eu mi quis lacinia. Ut aliquet eu mi quis lacinia. Ut
fermentum a magna ut eleifend. fermentum a magna ut eleifend. fermentum a magna ut eleifend.
Integer convallis suscipit ante eu Integer convallis suscipit ante eu Integer convallis suscipit ante eu
varius. varius. varius.
19
Team 1
Mirjam Victoria Alexander

Nilsson Lindqvist Martensson
COO COB CFO
Angelica Mira Flora

Astrom Karlsson Berggren
Head of Operations Head of Technical Creative Director
20
Funding
Fund Category Fund Category

Lorem ipsum dolor sit amet, Lorem ipsum dolor sit amet,
$14,000 $12,000 consectetur adipiscing elit.
$32,000 $82,000
Fund Category Fund Category

Lorem ipsum dolor sit amet, Lorem ipsum dolor sit amet,
consectetur adipiscing elit. consectetur adipiscing elit.
21
Summary
• Lorem ipsum dolor sit amet, consectetur Summary tagline or
adipiscing elit. Etiam aliquet eu mi quis
lacinia. sub-headline
• Ut fermentum a magna ut eleifend. Integer
convallis suscipit ante eu varius. Morbi a purus
dolor. Suspendisse sit amet ipsum finibus justo
viverra blandit.
• Ut congue quis tortor eget sodales. Nulla a erat
eget nunc hendrerit ultrices eu.
22
THANK YOU
Allan Mattsson
+1 555-0100
allan@contoso.com
www.contoso.com
23
Customize this Template
Template Editing
Instructions and Feedback

Seoul White Korea Presentation

Încărcat de

Informații document

Descriere originală:

Titlu original

Drepturi de autor

Formate disponibile

Partajați acest document

Partajați sau inserați document

Opțiuni de partajare

Vi se pare util acest document?

Este necorespunzător acest conținut?

Drepturi de autor:

Formate disponibile

Seoul White Korea Presentation

Încărcat de

Drepturi de autor:

Formate disponibile

SEOUL WHITE

Declining Market Financial Trust Cost Margins

Contoso Pharmaceuticals Competitor

Phase 1 Phase 2 Phase 3

Vendors Users Gross Company Gross Revenue

20YY 200 2000 $135,000 $20,250

20YY 400 4000 $270,000 $40,500 $0

Trials Marketing Launch

Legislation Investment Procurement

• Product Development 562,500 2 400,000 10 800,000 5%

EBIT -1 968,750 -4 800,000 28 080,000 13%

Mirjam Nils Victoria Lindqvist Angelica Astrom

Mirjam Victoria Alexander

Angelica Mira Flora

Fund Category Fund Category

Fund Category Fund Category

S-ar putea să vă placă și